Health insurance exchanges are poised to dramatically alter the interactions between insurers, consumers and pharmaceutical companies; pharmaceutical firms will need to carefully assess strategic objectives and appropriate resource allocation on a state-by-state basis.

To learn more, please download the free research highlights above.